Update on management of ovarian hyperstimulation syndrome

被引:28
作者
Chen, Chin-Der [1 ,2 ]
Wu, Mng Ying [1 ,2 ]
Chao, Kuang-Han [1 ,2 ]
Lien, Yih-Ron [1 ,2 ]
Chen, Shee-Uan [1 ,2 ]
Yang, Yu-Shih [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
来源
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY | 2011年 / 50卷 / 01期
关键词
Abdominal compartment syndrome; Dopamine agonist; Intra-abdominal pressure; Ovarian hyperstimulation syndrome; Paracentesis; ABDOMINAL COMPARTMENT SYNDROME; ENDOTHELIAL GROWTH-FACTOR; DOPAMINE AGONIST CABERGOLINE; UP-REGULATES EXPRESSION; GRANULOSA-LUTEIN CELLS; INTRAABDOMINAL HYPERTENSION; HYPERTONIC SALINE; INTRAVENOUS ALBUMIN; INTERNATIONAL-CONFERENCE; FOLLICULAR-FLUID;
D O I
10.1016/j.tjog.2011.01.014
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian hyperstimulation syndrome (OHSS) is a relatively common complication of ovarian stimulation and can be life threatening. The pathophysiology of OHSS is characterized by increased capillary permeability, leading to leakage of fluid from the vascular compartment, with third-space fluid accumulation and intravascular dehydration. The increased intra-abdominal pressure indicated that OHSS may be considered a compartment syndrome. Vascular endothelial growth factor, also known as vascular permeability factor, has emerged as one of the mediators intrinsic to the development of OHSS. Conventional management is focused on supportive care until the spontaneous resolution of the condition. The standard of care for treatment-monitoring of appropriate clinical parameters, fluid balance management, thrombosis prophylaxis, and ascites treatment-should prevent severe morbidity in most cases. This review will cover inpatient and outpatient management. The potential therapeutic approach targeting the vascular endothelial growth factor system will be discussed. Copyright (C) 2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:2 / 10
页数:9
相关论文
共 79 条
[1]   Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome [J].
Abuzeid, MI ;
Nassar, Z ;
Massaad, Z ;
Weiss, M ;
Ashraf, M ;
Fakih, M .
HUMAN REPRODUCTION, 2003, 18 (02) :370-373
[2]   A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome [J].
Al-Ramahi, M ;
Leader, A ;
Claman, P ;
Spence, J .
HUMAN REPRODUCTION, 1997, 12 (12) :2614-2616
[3]   Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment:: a pilot study [J].
Alvarez, Claudio ;
Alonso-Muriel, Isabel ;
Garcia, Gabriela ;
Crespo, Juana ;
Bellver, Jose ;
Simon, Carlos ;
Pellicer, Antonio .
HUMAN REPRODUCTION, 2007, 22 (12) :3210-3214
[4]   Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction [J].
Alvarez, Claudio ;
Marti-Bonmati, Luis ;
Novella-Maestre, Edurne ;
Sanz, Roberto ;
Gomez, Raul ;
Fernandez-Sanchez, Manuel ;
Simon, Carlos ;
Pellicer, Antonio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2931-2937
[5]   Ovarian hyperstimulation syndrome [J].
不详 .
FERTILITY AND STERILITY, 2008, 90 :S188-S193
[6]   Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease [J].
Antonini, Angelo ;
Poewe, Werner .
LANCET NEUROLOGY, 2007, 6 (09) :826-829
[7]   TREATMENT OF SYMPTOMATIC HYPONATREMIA AND ITS RELATION TO BRAIN-DAMAGE - A PROSPECTIVE-STUDY [J].
AYUS, JC ;
KROTHAPALLI, RK ;
ARIEFF, AI .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (19) :1190-1195
[8]   The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor [J].
Basu, S ;
Nagy, JA ;
Pal, S ;
Vasile, E ;
Eckelhoefer, IA ;
Bliss, VS ;
Manseau, EJ ;
Dasgupta, PS ;
Dvorak, HF ;
Mukhopadhyay, D .
NATURE MEDICINE, 2001, 7 (05) :569-574
[9]   Compressive pleural effusion after ovarian hyperstimulation syndrome-a case report and review [J].
Beji, Olfa ;
Brahmi, Nozha ;
Thabet, Hafedh ;
Mokline, Amel ;
Abidi, Nour ;
Blel, Youssef ;
Kouraichi, Nadia ;
Amamou, Mouldi .
FERTILITY AND STERILITY, 2008, 89 (06) :1826.e1-1826.e3
[10]   The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial† [J].
Busso, Cristiano ;
Fernandez-Sanchez, Manuel ;
Antonio Garcia-Velasco, Juan ;
Landeras, Jose ;
Ballesteros, Augustin ;
Munoz, Elkin ;
Gonzalez, Sandra ;
Simon, Carlos ;
Arce, Joan-Carles ;
Pellicer, Antonio .
HUMAN REPRODUCTION, 2010, 25 (04) :995-1004